TA
HSCS icon

TFB Advisors’s Heart Test Laboratories HSCS Stock Holding History

TFB Advisors’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.6K Hold
29,740
– – 0.03% 190
2026
Q1 		$74.8K Hold
29,740
– – 0.04% 180
2025
Q4 		$91.9K Hold
29,740
– – 0.03% 305
2025
Q3 		$105K Buy
+29,740
New +$108K 0.03% 305

Other funds holding HSCS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TFB Advisors's HSCS Position: Q2 2026 in Review

TFB Advisors held its Heart Test Laboratories (HSCS) position steady in Q2 2026 at 29,740 shares worth $74.6K. The position accounts for 0.03% of the portfolio, ranked #190.

TFB Advisors first reported a position in HSCS in Q3 2025 and has held it in 4 quarters since. The position peaked at $105K in Q3 2025. 16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

  • TFB Advisors held 29,740 shares of Heart Test Laboratories worth $74.6K as of Q2 2026.
  • TFB Advisors left its Heart Test Laboratories share count unchanged in Q2 2026.
  • Heart Test Laboratories made up 0.03% of TFB Advisors's portfolio in Q2 2026, its #190 holding.
  • TFB Advisors first reported a position in Heart Test Laboratories in Q3 2025 and has held it in 4 quarters since.
  • TFB Advisors's Heart Test Laboratories position peaked at $105K in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on TFB Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.